BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19137218)

  • 1. [The REACH legislation: the consumer and environment protection perspective].
    Gundert-Remy U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1426-33. PubMed ID: 19137218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Legal aspects of the REACH regulation. The control system of the REACH regulation--new approaches in the EU chemical legislation].
    Pache E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1408-16. PubMed ID: 19137216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk assessment and chemical safety under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1387-97. PubMed ID: 19137214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Responsibilities of the European Chemical Agency under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1398-407. PubMed ID: 19137215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REACH: the guidance documents of the European Chemicals Agency (ECHA)].
    Lulei M;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1444-52. PubMed ID: 19137220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [REACH--an ambitious project on the path to chemical safety].
    Foth H; Kahl R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1379-80. PubMed ID: 19137212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evidence-based toxicological evaluation of chemicals by group summaries].
    Greim H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1417-25. PubMed ID: 19137217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. That which must not, can not be... A reply to the EChA and EDF responses to the REACH analysis of animal use and costs.
    Hartung T; Rovida C
    ALTEX; 2009; 26(4):307-11. PubMed ID: 20957835
    [No Abstract]   [Full Text] [Related]  

  • 10. Narrow-and-sharp or broad-and-blunt--regulations of hazardous chemicals in consumer products in the European Union.
    Molander L; Rudén C
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):523-31. PubMed ID: 22107914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Historical development of the European legislation on chemicals].
    Bolt HM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1381-6. PubMed ID: 19137213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept of REACH and impact on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jan; 27(1):5-21. PubMed ID: 18480145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REACH and reproductive and developmental toxicology: still questions.
    Scialli AR; Guikema AJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):63-9. PubMed ID: 22239083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of toxicological evaluations for dermal exposure performed under two different EU regulatory frameworks.
    Westerholm E; Schenk L
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):51-8. PubMed ID: 24269627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European experience in chemicals management: integrating science into policy.
    Christensen FM; Eisenreich SJ; Rasmussen K; Sintes JR; Sokull-Kluettgen B; Van de Plassche EJ
    Environ Sci Technol; 2011 Jan; 45(1):80-9. PubMed ID: 20958022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure-driven risk assessment: applying exposure-based waiving of toxicity tests under REACH.
    Rowbotham AL; Gibson RM
    Food Chem Toxicol; 2011 Aug; 49(8):1661-73. PubMed ID: 21458516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.